Junlong Liu
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.
Journal: Cancer medicine
Published: February 20, 2022
Primary bladder schwannoma: a case report and literature review.
Journal: Translational cancer research
Published: January 30, 2021
SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.
Journal: Journal of cellular and molecular medicine
Published: October 01, 2020
Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein Abundance.
Journal: Cancer management and research
Published: July 26, 2020
Mammalian SIRT4 is a tumor suppressor of clear cell renal cell carcinoma by inhibiting cancer proliferation, migration and invasion.
Journal: Cancer biomarkers : section A of Disease markers
Published: July 18, 2020
Knockdown of MAPK14 inhibits the proliferation and migration of clear cell renal cell carcinoma by downregulating the expression of CDC25B.
Journal: Cancer medicine
Published: October 02, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026